Method Of Inhibiting Biomaterial-induced Procoagulant Activity Using Complement Inhibitors

  • Published: Apr 8, 2010
  • Earliest Priority: Sep 30 2008
  • Family: 9
  • Cited Works: 0
  • Cited by: 0
  • Cites: 0
  • Sequences: 5
  • Additional Info: Published Sequence
Full-text?

The full document isn't yet available to us from the patent office, but we've found a related patent (family member) to use for our images and PDF.

Abstract

Methods for reducing or eliminating biomaterial-induced procoagulant activity in blood subjected to extracorporeal treatment that exposes the blood to the biomaterial are disclosed. The methods involve treatment of the blood, or the extracorporeal biomaterial, or both, with a complement inhibitor to inhibit C5a/C5aR-mediated tissue factor formation in the blood.


Claims

Information currently unavailable.

Family Member PDF
Family Member Preview
These are the images from a related family member, as the full document isn't yet available to us from the patent office.
Document History
  • Publication: Apr 8, 2010
  • Application: Sep 29, 2009
    CA CA 2738930 A
  • Priority: Sep 29, 2009
    US US 2009/0058745 W
  • Priority: Sep 30, 2008
    US US 10145308 P

Download Citation


Sign in to the Lens

Feedback